BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 22275754)

  • 1. The calcium-sensing receptor complements parathyroid hormone-induced bone turnover in discrete skeletal compartments in mice.
    Xue Y; Xiao Y; Liu J; Karaplis AC; Pollak MR; Brown EM; Miao D; Goltzman D
    Am J Physiol Endocrinol Metab; 2012 Apr; 302(7):E841-51. PubMed ID: 22275754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anabolic action of parathyroid hormone is skeletal site specific at the tissue and cellular levels in mice.
    Iida-Klein A; Zhou H; Lu SS; Levine LR; Ducayen-Knowles M; Dempster DW; Nieves J; Lindsay R
    J Bone Miner Res; 2002 May; 17(5):808-16. PubMed ID: 12009011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex and age modify biochemical and skeletal manifestations of chronic hyperparathyroidism by altering target organ responses to Ca2+ and parathyroid hormone in mice.
    Cheng Z; Liang N; Chen TH; Li A; Santa Maria C; You M; Ho H; Song F; Bikle D; Tu C; Shoback D; Chang W
    J Bone Miner Res; 2013 May; 28(5):1087-100. PubMed ID: 23239173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative study of the bone metabolic response to dried plum supplementation and PTH treatment in adult, osteopenic ovariectomized rat.
    Smith BJ; Bu SY; Wang Y; Rendina E; Lim YF; Marlow D; Clarke SL; Cullen DM; Lucas EA
    Bone; 2014 Jan; 58():151-9. PubMed ID: 24125756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic effects of high dietary calcium and exogenous parathyroid hormone in promoting osteoblastic bone formation in mice.
    Feng Y; Zhou M; Zhang Q; Liu H; Xu Y; Shu L; Zhang J; Miao D; Ren Y
    Br J Nutr; 2015 Mar; 113(6):909-22. PubMed ID: 25744000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of treatment for 6 months with human parathyroid hormone (1-34) peptide in ovariectomized cynomolgus monkeys (Macaca fascicularis).
    Jerome CP; Johnson CS; Vafai HT; Kaplan KC; Bailey J; Capwell B; Fraser F; Hansen L; Ramsay H; Shadoan M; Lees CJ; Thomsen JS; Mosekilde L
    Bone; 1999 Sep; 25(3):301-9. PubMed ID: 10495134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term continuous infusion of human parathyroid hormone 1-34 fragment is catabolic with decreased trabecular connectivity density accompanied by hypercalcemia in C57BL/J6 mice.
    Iida-Klein A; Lu SS; Kapadia R; Burkhart M; Moreno A; Dempster DW; Lindsay R
    J Endocrinol; 2005 Sep; 186(3):549-57. PubMed ID: 16135674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The calcium-sensing receptor in bone--mechanistic and therapeutic insights.
    Goltzman D; Hendy GN
    Nat Rev Endocrinol; 2015 May; 11(5):298-307. PubMed ID: 25752283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The calcium-sensing receptor (CaSR) defends against hypercalcemia independently of its regulation of parathyroid hormone secretion.
    Kantham L; Quinn SJ; Egbuna OI; Baxi K; Butters R; Pang JL; Pollak MR; Goltzman D; Brown EM
    Am J Physiol Endocrinol Metab; 2009 Oct; 297(4):E915-23. PubMed ID: 19797241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitogen-activated protein kinase phosphatase 1 regulates bone mass, osteoblast gene expression, and responsiveness to parathyroid hormone.
    Mahalingam CD; Datta T; Patil RV; Kreider J; Bonfil RD; Kirkwood KL; Goldstein SA; Abou-Samra AB; Datta NS
    J Endocrinol; 2011 Nov; 211(2):145-56. PubMed ID: 21852324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous parathyroid hormone-related protein compensates for the absence of parathyroid hormone in promoting bone accrual in vivo in a model of bone marrow ablation.
    Zhu Q; Zhou X; Zhu M; Wang Q; Goltzman D; Karaplis A; Miao D
    J Bone Miner Res; 2013 Sep; 28(9):1898-911. PubMed ID: 23716486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mice lacking bone sialoprotein (BSP) lose bone after ovariectomy and display skeletal site-specific response to intermittent PTH treatment.
    Wade-Gueye NM; Boudiffa M; Laroche N; Vanden-Bossche A; Fournier C; Aubin JE; Vico L; Lafage-Proust MH; Malaval L
    Endocrinology; 2010 Nov; 151(11):5103-13. PubMed ID: 20844009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous expression analysis of vitamin D receptor, calcium-sensing receptor, cyclin D1, and PTH in symptomatic primary hyperparathyroidism in Asian Indians.
    Varshney S; Bhadada SK; Saikia UN; Sachdeva N; Behera A; Arya AK; Sharma S; Bhansali A; Mithal A; Rao SD
    Eur J Endocrinol; 2013 Jul; 169(1):109-16. PubMed ID: 23660642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The skeleton in primary hyperparathyroidism: a review focusing on bone remodeling, structure, mass, and fracture.
    Christiansen P
    APMIS Suppl; 2001; (102):1-52. PubMed ID: 11419022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parathyroid-Targeted Overexpression of Regulator of G-Protein Signaling 5 (RGS5) Causes Hyperparathyroidism in Transgenic Mice.
    Balenga N; Koh J; Azimzadeh P; Hogue J; Gabr M; Stains JP; Olson JA
    J Bone Miner Res; 2019 May; 34(5):955-963. PubMed ID: 30690792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accentuated osteoclastic response to parathyroid hormone undermines bone mass acquisition in osteonectin-null mice.
    Machado do Reis L; Kessler CB; Adams DJ; Lorenzo J; Jorgetti V; Delany AM
    Bone; 2008 Aug; 43(2):264-273. PubMed ID: 18499553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gender differences in the response of CD-1 mouse bone to parathyroid hormone: potential role of IGF-I.
    Wang Y; Sakata T; Elalieh HZ; Munson SJ; Burghardt A; Majumdar S; Halloran BP; Bikle DD
    J Endocrinol; 2006 May; 189(2):279-87. PubMed ID: 16648295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parathyroid hormone (PTH)/PTH-related peptide type 1 receptor (PPR) signaling in osteocytes regulates anabolic and catabolic skeletal responses to PTH.
    Saini V; Marengi DA; Barry KJ; Fulzele KS; Heiden E; Liu X; Dedic C; Maeda A; Lotinun S; Baron R; Pajevic PD
    J Biol Chem; 2013 Jul; 288(28):20122-34. PubMed ID: 23729679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CREM deficiency in mice alters the response of bone to intermittent parathyroid hormone treatment.
    Liu F; Lee SK; Adams DJ; Gronowicz GA; Kream BE
    Bone; 2007 Apr; 40(4):1135-43. PubMed ID: 17275432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skeletal changes in osteoprotegerin and receptor activator of nuclear factor-kappab ligand mRNA levels in primary hyperparathyroidism: effect of parathyroidectomy and association with bone metabolism.
    Stilgren LS; Rettmer E; Eriksen EF; Hegedüs L; Beck-Nielsen H; Abrahamsen B
    Bone; 2004 Jul; 35(1):256-65. PubMed ID: 15207766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.